Skip to content

The Dutch ITP-registry, a national web-based tool for collection of diagnostic, therapeutical and evaluation data from patients with chronic immune trombocytopenic purpura.

Start treatment in chronic ITP (STiC) registry.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON21674
Enrollment
300
Registered
2010-04-28
Start date
2010-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Number of patients treated. Effectivity, safety and cost-effectiveness of different treatment modalities, quality of life.

Interventions

None listed

Sponsors

Dutch working party on non-malignant hematology of the Dutch Society of Hematology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients (M/F) with chronic or persistent ITP (with history of splenectomy) needing additional treatment (inc. wait-and-see patients qualifying for ITP but not activily being treated but in follow-up).

Exclusion criteria

Exclusion criteria: 1. Minors; 2. Patients with acute or secundairy ITP.

Design outcomes

Primary

MeasureTime frame
1. How many patients need a treatment for chronic ITP; 2. Does the treatment work in non-selected patient group with chronic ITP; 3. What is the frequency and severity of side effects induced by new drugs in a non-selected patients group with chronic ITP; 4. What is the cost-effectiveness.

Secondary

MeasureTime frame
Quality of life.

Contacts

Public ContactR. Fijheer

P.O.Box 1502

R.Fijnheer@meandermc.nl+31 (0)65 1155658

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)